相关实验视频
Updated: Jul 28, 2025

03:25
Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
5.6K
对于四个连续葡萄糖监测器,从2022年开始引起不良事件
1Krouwer Consulting, Sherborn, MA, USA.
Journal of diabetes science and technology
|June 2, 2023
概括
持续血糖监测器 (CGMs) 在2022年有281,963次不良事件. 根据原因分析这些事件有助于减少糖尿病患者未来的问题.
科学领域:
- 医疗器械 医疗器械
- 糖尿病 技术 技术
- 患者安全 患者安全
背景情况:
- 持续血糖监测器 (CGM) 对于糖尿病管理至关重要.
- 有相当多的不良事件 (在2022年为281,963例) 与CGM相关.
- 了解这些不良事件对于提高患者安全至关重要.
研究的目的:
- 审查获取CGM不良事件数据的过程.
- 分析报告给美国食品和药物管理局 (FDA) 的不良事件的原因.
- 识别CGM故障和损伤的常见和特定于设备的原因.
主要方法:
- 从FDA数据库中提取了四种主要CGM产品的不良事件.
- 数据是使用SQL Server组织的,根据故障或损伤对事件进行分类.
- 通过分析不良事件的文字描述来确定原因,而不仅仅依赖制造商代码.
主要成果:
- 常见的原因包括阻止用户获取读数和设备不准确的事件.
- 具体原因因特定的CGM装置而异.
- 分析显示,需要超越制造商代码来了解根本原因.
结论:
- 按制造商和事件类型对CGM不良事件数据进行结构化,然后进行文本分析,有助于识别原因.
- 分析不良事件数据是缓解问题的关键第一步.
- 这种系统的方法可以提高糖尿病患者使用CGM的安全性和可靠性.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Dipeptidyl Peptidase 4 Inhibitors
216
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
216
Hypoglycemia and Glucagon
306
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Errors occurring during blood pressure monitoring
798
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
798
Holter Monitor: 24-Hour Monitoring
73
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
73
Diabetes: Symptoms, Diagnosis, and Complications
606
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
606

